These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21422866)

  • 1. Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial.
    Lee YK; Chung HH; Kim JW; Park NH; Song YS; Kang SB
    Obstet Gynecol; 2011 Apr; 117(4):922-927. PubMed ID: 21422866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a pH-Balanced Vaginal Gel on Dyspareunia and Sexual Function in Breast Cancer Survivors Who Were Premenopausal at Diagnosis: A Randomized Controlled Trial.
    Kim YH; Park S; Lee M; Hahn S; Jeon MJ
    Obstet Gynecol; 2017 May; 129(5):870-876. PubMed ID: 28383379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.
    Bachmann G; Bouchard C; Hoppe D; Ranganath R; Altomare C; Vieweg A; Graepel J; Helzner E
    Menopause; 2009; 16(4):719-27. PubMed ID: 19436223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
    Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrophic vaginitis.
    Stika CS
    Dermatol Ther; 2010; 23(5):514-22. PubMed ID: 20868405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
    Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH
    Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Fractional Carbon Dioxide vs Sham Laser on Sexual Function in Survivors of Breast Cancer Receiving Aromatase Inhibitors for Genitourinary Syndrome of Menopause: The LIGHT Randomized Clinical Trial.
    Mension E; Alonso I; Anglès-Acedo S; Ros C; Otero J; Villarino Á; Farré R; Saco A; Vega N; Castrejón N; Ordi J; Rakislova N; Tortajada M; Matas I; Gómez S; Ribera L; Castelo-Branco C
    JAMA Netw Open; 2023 Feb; 6(2):e2255697. PubMed ID: 36763359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
    Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
    Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study.
    Petersen EE; Magnani P
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):70-5. PubMed ID: 15474248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.
    Hirschberg AL; Sánchez-Rovira P; Presa-Lorite J; Campos-Delgado M; Gil-Gil M; Lidbrink E; Suárez-Almarza J; Nieto-Magro C
    Menopause; 2020 May; 27(5):526-534. PubMed ID: 32049923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
    Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
    Chen J; Geng L; Song X; Li H; Giordan N; Liao Q
    J Sex Med; 2013 Jun; 10(6):1575-84. PubMed ID: 23574713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial.
    Zohrabi I; Abedi P; Ansari S; Maraghi E; Shakiba Maram N; Houshmand G
    BMC Womens Health; 2020 May; 20(1):108. PubMed ID: 32429977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P
    Arch Gynecol Obstet; 2013 Dec; 288(6):1199-201. PubMed ID: 24178484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment of vaginal atrophy with isoflavone vaginal gel.
    Lima SM; Yamada SS; Reis BF; Postigo S; Galvão da Silva MA; Aoki T
    Maturitas; 2013 Mar; 74(3):252-8. PubMed ID: 23312487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.
    Loprinzi CL; Abu-Ghazaleh S; Sloan JA; vanHaelst-Pisani C; Hammer AM; Rowland KM; Law M; Windschitl HE; Kaur JS; Ellison N
    J Clin Oncol; 1997 Mar; 15(3):969-73. PubMed ID: 9060535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial.
    Mitchell CM; Reed SD; Diem S; Larson JC; Newton KM; Ensrud KE; LaCroix AZ; Caan B; Guthrie KA
    JAMA Intern Med; 2018 May; 178(5):681-690. PubMed ID: 29554173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of an acidic vaginal gel on vaginal pH and interleukin-6 levels in low-risk pregnant women: a double-blind, randomized placebo-controlled trial.
    Paternoster DM; Tudor L; Milani M; Maggino T; Ambrosini A
    J Matern Fetal Neonatal Med; 2004 Mar; 15(3):198-201. PubMed ID: 15280147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.
    Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J
    Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.